Featuring the fruits and vegetables grown in Kampung Bugis, Bintan, this book highlights the importance of eating fruits and vegetables, including its health benefits, how to include them in our diet, and other tips to ensure good quality of these fruits and vegetables.
Esco Lifesciences Group is currently taking decisive steps toward sustainability at the core of its business operations. As a world-leading life sciences company, Esco has a diverse portfolio that includes manufacturing equipment for laboratories, biopharma, and IVF medical devices. With three manufacturing sites located in China, Lithuania, and Bintan, Indonesia, the Bintan site under PT Esco Bintan Indonesia (Esco Bintan) is Esco's largest manufacturing facility. This book aims to help readers understand the concept, history, and implementation of sustainability in business through an Indonesian lends, focusing on its application in Indonesia. Using Esco Bintan as a model, the book provides examples of how a company should and could implement sustainability in business.
Esco reflects the importance of giving back, empowering the local community and promoting Bintan’s beautiful and unique marine cultivation and cuisine. The Art of Fine Dining shows how local and international cuisine are created from farm to table, the Esco way. In line with Esco’s vision of making human lives healthier and safer, we made sure that our staff experience the very best in food (that are guaranteed healthy and organic), service, and atmosphere.
Duyung or dugongs (Dugong dugon) are a type of marine mammal which is a member of the Sirenia or sea cows that still survive besides manatees and can reach ages of 22 to 25 years. Dugongs are not fish because they suckle their young and are still an evolutionary relative of elephants. It is also the only sea elephant that can be found in the waters of at least 37 countries in the Indo-Pacific region, although most dugongs live in eastern Indonesia and northern Australia.
In this issue, The HQ focuses on the continuously emerging COVID-19 variants. As mutations continue to arise and the spread of the virus is still prevalent, vaccine roll-outs with desired herd immunity to end the pandemic is still far from sight. Esco anticipates the need for scale-up solutions in providing leading-edge technologies to support stakeholders in producing top-of-the-line quality vaccines.
